Building Ecosystem Success
The BIONATION gathering in Ottawa was inspiring to all who were able to participate. Canada’s biotech ecosystem is truly a remarkable economic and social asset. The sector’s emerging innovations and leaders provide great optimism for addressing global health, environmental and social challenges.
On behalf of the speakers and panelists, BIOTECanada has made a donation to the Canadian Red Cross for those impacted by Hurricane Fiona in the Atlantic provinces. The Government of Canada will match donations made to the Hurricane Fiona in Canada Appeal by Canadians and corporations up to October 23, 2022.
Finally, a recognition of the BIONATION 2022 partners: adMare BioInnovations; BioTalent Canada; Fonds de Solidarite FTQ; Genome Canada; and, Roche Canada Pharma. Who’s strong support of the BIONATION initiative contributed significantly to its success. Thank you.
Timothy Caulfield | Mis-information Overload
Bringing his trademarked energy to the stage, the audience was in rapt attention as Professor Timothy Caulfield, an unrivaled communicator debunked myths and assumptions about innovation in the health sector — from research on stem cells to diets to alternative medicine — for the benefit of the public and decision-makers.
Showcasing smarts and charm, Timothy Caulfield engages celebrities and those casting doubt about the value of vaccines through social media on a daily basis. Check out his recent ScienceUpFirst initiative here.
Minister Duclos Discusses Industry Goals and Government Action
BIONATION welcomed Jean-Yves Duclos, Minister of Health. Not surprisingly, the pandemic’s economic, social, and health impact has effectively focussed the attention of policymakers and the public on the strategic importance of building a competitive domestic life sciences industry and biomanufacturing capacity. Importantly, Canada is building this capacity from a position of strength.
As the biotechnology industry has strengthened its capacity with knowledge, expertise, and investment, so has government policy as Canada seeks to capitalize on generations of leadership from biotechnology researchers and entrepreneurs.
Moderated by Rosemary Thompson (Coalition for a Better Future), panelists Bettina Hamelin (Ontario Genomics), Jean-Pierre Baylet (Sanofi Vaccines), and Oliver Technow (BIOVECTRA) explored what has been working, the government’s biomanufacturing initiative and what is next for this partnership.
adMare BioInnovations and Genome Canada Partner to Drive Commercialization of Genomics Solutions in Healthcare
At BIONATION, the leaders of Genome Canada and adMare BioInnovations announced a new strategic partnership to support the translation of genomics research into commercialization opportunities in healthcare.
By leveraging the individual strengths, networks, programs, and expertise of Genome Canada and adMare, the goal of the new memorandum of understanding signed today is to engage in concrete joint activities that will strengthen the university-to-company innovation pipeline in Canada’s life sciences ecosystem—accelerating and maximizing impact in the healthcare and pharmaceutical sectors.
Seeding, Scaling, and Growing in a Global Environment
In the coming years, more than $80 billion of global investment is targeted for the sector. Canada has been building its competitiveness to attract some of that investment. How is/will Canada compete to attract the capital needed to sustain and grow the life sciences industry?
Moderated by Geneviève Guertin (Fonds de la Solidarité FTQ), panelists Felipe Velasquez (JP Morgan), Anne Woods (Silicon Valley Bank), Gordon McCauley (adMare BioInnovations), and Ali Tehrani (Amplitude Ventures) discussed the record-setting global investment into life sciences for the past few years.
Inspirational Lessons from Hayley Wickenheiser
Seven World Championships; Six Olympic appearances; Five Olympic medals; Four Olympic Gold medals – Hayley Wickenheiser is a titan of sport and a leader both on and off the ice. Hayley took the BIONATION audience through her unique story of overcoming challenges and experiencing incredible heights in the world of sports and medicine. Hayley’s sincerity and humbleness were on full display as she balances her current roles in a Family Medicine residency while maintaining a position as the Senior Director of Player Development for the Toronto Maple Leafs.
Next Generation: Exploring the Horizon of Solutions Powering the Ecosystem
With biotechnology at the forefront of solutions for human health, technology convergence sets the agenda for the next generation of therapies. From data to AI, the spectrum of potential is truly awe-inspiring.
Moderated by Brigitte Nolet (Roche Canada Pharma), panelists Eric Roos (Aspect Biosystems), John Weigelt (Microsoft Canada), and Laurent Tillement (Mila Quebec AI Institute) discussed the innovations of today and how they are leading the solutions of tomorrow.
Check out some recent media highlights discussing industry investments and strategies representing an important and timely opportunity to accelerate the growth and global competitiveness of Canada’s biotech sector
How to Grow Canada’s Biotech Sector, The Future Economy
Canada’s biotech ecosystem at an inflection point, iPolitics
Fall issue of insights magazine featuring Roche, Fonds de la Solidarite FTQ, Bioenterprise, VIDO, OmniaBio, Atlantic Clinical Trials Network, and more.